Skip to main content

Table 2 Comparison of laboratory and clinical parameters from active (NOT LTFU) and inactive (LTFU) patients

From: Patterns and patient factors associated with loss to follow-up in the Muhimbili sickle cell cohort, Tanzania

 

Active patients (NOT LTFU)

Inactive patients (LTFU exclude those reported dead)

 

Median

IQR

Median

IQR

Test Statistics

Age

13.00

07.00–19.00

11.00

07.00–15.00

t = 5.696 (p < 0.001)

White blood cell (WBC) (10^3/uL)

13.11

10.69–16.60

13.65

10.90–17.19

t = −0.9953 (0.3197)

Neutrophils (%)

46.50

38.80–54.52

45.20

38.10–53.25

t = 1.9524 (p = 0.0509)

Hemoglobin (g/dL)

07.40

06.60–08.30

07.40

6.70–08.20

t = 0.0620 (p = 0.9505)

Red Blood Cells (RBC) (10^6/uL)

02.85

02.42–03.33

02.83

2.44–3.28

t = 0.1212 (p = 0.9036)

Mean Cell Volume (MCV) (fL)

78.58

72.00–85.20

77.40

71.50–83.80

t = 2.3742 (p = 0.0177)

Mean Cell Hemoglobin Concentration (MCHC)(g/dL)

33.33

31.60–34.90

33.80

32.27–35.10

t = −4.0359 (p < 0.001)

Red Cell Distribution Width (RDW) (%)

22.00

19.70–24.40

22.30

19.80–24.70

t = −0.2216 (p = 0.8247)

Platelets (10^3/uL)

417.00

304.00–522.00

409.50

312–522

t = −0.0655 (p = 0.9478)

Haematocrit (%)

22.22

19.70–22.20

22.80

19.60–24.50

t = 1.5341 (p = 0.1251)